Univo IRB is proud to share that CEO Julie Blasingim has been honored with two prestigious awards recognizing her leadership and long-standing impact in the clinical research industry.
Julie was named one of 1nHealth’s 2025 Patient Engagement Leaders — an award celebrating those who are actively reshaping clinical trials through patient-centered strategies. Honorees were selected for their vision, integrity, and contributions to making research more accessible, inclusive, and transparent at every step.
Julie was also recognized as one of The Top 50 Women Leaders of North Carolina for 2025 by Women We Admire, an organization that lifts up female executives in the United States and Canada. Julie was included on the list for her strong female leadership driving improvements in her industry and her professional footprint on Raleigh- Durham and life sciences community..
With over two decades of experience in IRB operations, research ethics, and executive leadership, Julie continues to be a national voice for participant protection and regulatory excellence. These awards are yet another example of her impressive compassion and tenacious advancement of Univo IRB’s mission: to unify research with our passion for patient participation, education, and advocacy.
To learn more about Univo IRB’s mission, visit our Unifying Patients & Research page.
